Speaker at Drug Discovery World Asia: Dr Olivier Heudi, #Norvatis Institute for Biomedical Research

The featured speaker for this post is Dr Olivier Heudi, Head, Translational Sciences, Norvatis Institute for Biomedical Research, Switzerland. On the 21st of March, Dr Heudi will be making at presentation at Drug Discovery World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012, held at Marina Bay Sands, Singapore. Dr Heudi obtained …

Hear more about #medicinalchemistry outsourcing from Dr David Wadsworth

On the 20th March 2012, Dr David Wadsworth will be presenting on medicinal chemistry outsourcing atDrug Discovery World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012, held at Marina Bay Sands, Singapore. Dr Wadsworth carried out his Ph.D work at Imperial College, London, joining Ciba-Geigy in Basel as a Research Chemist in …

Drug Discovery; “Where it all begins.”

Drug Discovery (#DrugDiscovery) and Development (#ClinicalTrials) follows a cycle which roughly stays the same globally. In just a few moments you will know more about "How does it all start?" Necessity is the mother of all inventions. And the need for survival comes above all, which enables the Pharmaceutical industry to be one of the biggest industries in the world. …

Featured speaker: Mr Kottepa Pari, Piramal Healthcare, India

This post today features our speaker from Drug Discovery World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012, held on 19-22 March at Marina Bay Sands, Singapore. Firstly, a brief introduction. Dr Kottepa Pari joined the Piramal Group in 2005. Currenly he is the Senior Group Leader and Head of Discovery Analytical …

Driving productivity with an automated nanoliter scale #immunoassay platform – #download

Discover how to increase prodcutivity with an automated nanoliter scale immunoassay platform from Karolina Österlund, Manager Field Application Specialists, EU and Asia, Gyros AB, Sweden. Ms. Österlund brings her expertise in ligand binding assays to support development of biotherapeutics as well as implementation of Gyros technology to the Asia-Pacific region. She has been providing technical support for the Gyrolab immunoassay …

“Low Costs and Fast Approvals”. The appealing package, inviting countries to the East.

Drug discovery (#Drugdiscovery) practices in the western countries are getting harder over time due to the increasing costs, growing complexity, and longer timelines. These are some of the most daunting clinical research challenges a drug discovery company faces today. In such hard times, drug discovery (#DrugDiscovery) companies are turning towards India and China for mutually beneficial reasons. Over the years, …

Commercialise your #celltherapy and improve your #drug discovery with #stemcells

The 7th Annual World Stem Cells & Regenerative Medicine Congress (co-located with the inaugural World Gene Therapy Congress) is taking place on the 21st-23rd May 2012 at the Victoria Park Plaza in London, UK. STREAM A – Cell Therapy & Regenerative Medicine · Make sure your leading cell therapy reaches the patients by identifying a scalable and economical commercialisation strategy …

Uncovering opportunities for new drugs to treat #cardiometabolic diseases – #downloads

Discover new opportunities to treat cardiometabolic diseases from Dr. Rebecca Taub, Senior Vice President, VIA Pharmaceuticals, USA. Rebecca A. Taub, M.D. has served as Senior Vice President, Research and Development of VIA Pharmaceuticals sincee 2008. At VIA, she leads the efforts in Cardiometabolic drug discovery and development. From 2004-2008, she was Vicee President, Research, Metabolic Diseases at Hoffman-La Roche focusing …